Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Weight Loss 1Neoplasms 1Fatigue 1Anorexia 1

Interventions

Modafinil 9Methylphenidate 4Saline Solution 3regorafenib 2Sugars 2Physical Therapy Modalities 2Exercise 2Dexamethasone 2reparixin 1ofatumumab 1epoetin beta 1eicosapentaenoic acid ethyl ester 1eicosapentaenoic acid ethanolamide 1clazakizumab 1caffeine, sodium benzoate drug combination 1Yoga 1Walking 1Waiting Lists 1Vinorelbine 1Urinalysis 1Therapeutics 1Thalidomide 1Testosterone 1Sodium Chloride 1Proton Pump Inhibitors 1Patient Reported Outcome Measures 1Megestrol Acetate 1Lenalidomide 1Lactose 1Infliximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fatigue × EOM613 × Clear all
NCT01206335 2012-11-27

Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia

Ohr Pharmaceutical Inc.

Phase 2 Unknown
20 enrolled

Anorexia, Fatigue, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡